tiprankstipranks
Trending News
More News >
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market

TScan Therapeutics (TCRX) Revenue

Compare
218 Followers

TScan Therapeutics Revenue

TScan Therapeutics had a revenue of 665.00K in the quarter ending Dec 31, 2024, with -36.61%. This bring the company's revenue in the last twelve months to 2.82M, Increased -69.92%. In the fiscal year ending Dec 31, 2024, TScan Therapeutics had annual revenue of 2.82M with -86.62% growth.
Revenue (ttm)
2.82M
Revenue Growth
-86.62%
P/S Ratio
32.15
Revenue/Employee
$14,515
Employees
194
Market Cap
$90.55M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20242.82M-18.23M-86.62%
Dec 31, 202321.05M7.51M+55.52%
Dec 31, 202213.54M3.39M+33.47%
Dec 31, 202110.14M9.06M+834.65%
Dec 31, 20201.08M+∞%
Dec 31, 20190.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis